Toshiba America Medical Systems Inc. has received authorization to operate (ATO) with the U.S. Air Force for its Aplio Platinum Series ultrasound systems.
April 7, 2016 — Circle Cardiovascular Inc. the world-leading developer of innovative cardiac MR (CMR) and cardiac CT (CCT) post-processing software announces the completion of a substantial financing round with participation from existing investors including BDC Capital and new investors, The Accelerate Fund and Epic Capital Management Inc.
Emergency department patients with low-risk chest pain show improved knowledge of their health status and follow-up options after talking through treatment options with a physician, according to Mayo Clinic research.
April 7, 2016 — New data demonstrates that for aortic stenosis patients at intermediate-risk for open-heart surgery, transcatheter aortic valve replacement (TAVR) with the latest generation of balloon-expandable device is superior to surgery, resulting in better patient outcomes.
If you enjoy this content, please share it with a colleague
April 6, 2016 — Tests used to diagnose and assess the severity of coronary artery disease appear to function differently for women and men who have stable symptoms, according to researchers from Duke Clinical Research Institute.
The finding, presented April 4 at the American College of Cardiology (ACC) Scientific Sessions meeting in Chicago, adds new insights into the differences between men and women who are newly diagnosed with heart disease.
End-stage heart failure patients treated with stem cells harvested from their own bone marrow experienced 37 percent fewer cardiac events — including deaths and heart failure hospital admissions — than a placebo-controlled group, according to a new study.
North Fulton Hospital, Roswell, Ga., is one of the first healthcare providers in the United States to purchase the new Carestream Touch Prime XE Ultrasound System.
New research shows individuals with a greater degree of activity in the stress center of the brain also have more evidence of inflammation in their arteries and were at higher risk for cardiovascular events, including heart attack, stroke and death.
April 5, 2016 — Philips announced that a combined total of more than 5,000 patients have been enrolled in three prospective clinical studies to assess Philips Volcano’s proprietary iFR (instant wave-Free Ratio) measurement technology.
Chest pain and shortness of breath are the most common symptoms reported by both women and men with suspected heart disease, a finding in contrast to prior data.
